# The Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy

> **NCT02126709** · PHASE2 · UNKNOWN · sponsor: **National University Hospital, Singapore** · enrollment: 30 (estimated)

## Conditions studied

- Acne

## Interventions

- **DRUG:** Repigel

## Key facts

- **NCT ID:** NCT02126709
- **Lead sponsor:** National University Hospital, Singapore
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-06
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2014-04-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02126709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02126709, "The Efficacy and Safety of 3% Povidone-Iodine in Acne Therapy". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02126709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*